Journal article
Challenges for optimizing real-world evidence in Alzheimer’s disease: The ROADMAP Project
- Abstract:
- ROADMAP is a public-private advisory partnership to evaluate the usability of multiple data sources, including real-world evidence, in the decision-making process for new treatments in Alzheimer's disease, and to advance key concepts in disease and pharmacoeconomic modeling. ROADMAP identified key disease and patient outcomes for stakeholders to make informed funding and treatment decisions, provided advice on data integration methods and standards, and developed conceptual cost-effectiveness and disease models designed in part to assess whether early treatment provides long-term benefit.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 139.3KB, Terms of use)
-
- Publisher copy:
- 10.3233/jad-180370
Authors
- Publisher:
- IOS Press
- Journal:
- Journal of Alzheimer's Disease More from this journal
- Volume:
- 67
- Issue:
- 2
- Pages:
- 495-501
- Publication date:
- 2019-01-22
- Acceptance date:
- 2018-11-08
- DOI:
- EISSN:
-
1875-8908
- ISSN:
-
1387-2877
- Pmid:
-
30584137
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:955025
- UUID:
-
uuid:7f38ad29-dc05-483b-b6ea-828f8561cc49
- Local pid:
-
pubs:955025
- Source identifiers:
-
955025
- Deposit date:
-
2019-03-06
Terms of use
- Copyright holder:
- Gallacher et al
- Copyright date:
- 2019
- Notes:
- © 2019 – IOS Press and the authors. All rights reserved. This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC 4.0)
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record